A Review of the Current State of Off‐Label Therapies for Pediatric Inflammatory Bowel Disease

ABSTRACT Off‐label use of biologic therapies in patients with pediatric inflammatory bowel disease (IBD) has seen an increase in utilization. In this paper, we review the current state of off‐label therapies in the pediatric IBD population. Real‐world use of ustekinumab (UST), vedolizumab (VDZ), upa...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Yassin EL‐Najjar, Mary‐Joe Touma, Shuai Tan, Xiaoqin Zhou, Qi Liu
Natura: Artigo
Lingua:Inglês
Pubblicazione: Wiley 2025-06-01
Serie:Pediatric Discovery
Soggetti:
biologic therapy
Crohn’s disease (CD)
pediatric inflammatory bowel disease 
small molecule
ulcerative colitis (UC)
Accesso online:https://doi.org/10.1002/pdi3.70011
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi